Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00346073
Status:
COMPLETED
Last Update Posted:
2018-08-07
First Post:
2006-06-28
Brief Title:
Safety and Immunogenicity of GSKs Tdap Vaccine Boostrix in Adults Aged 19 to 64 Years
Sponsor:
Organization:
GlaxoSmithKline